CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 162 target
Drug / intervention
SBRTradiation
Likely dose
Not stated in record
Key inclusion· 5
  • ✓Histological diagnosis of malignancy
  • ✓Histologically or radiologically diagnosed bone metastasis
  • ✓Age 18 years or older
  • ✓Pain or under pain control medication
Key exclusion· 10
  • ✕Pregnant or lactating women
  • ✕Women of childbearing potential or sexually active males not willing to use effective contraception during treatment and 3 months after
  • ✕Inability to follow study procedures
  • ✕Prior radiotherapy to intended treatment site

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05406063
NCT05406063N/ARecruitingUpdate OverdueUpdated 13mo ago · Completion was 13mo ago
Enrollment Stalled
Long Recruiting
Update Overdue
CompareCT.gov

Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone Metastases a Multicentre Prospective, Open Label, Randomised Controlled Phase 3 Non-inferiority Clinical Trial

Kantonsspital Winterthur KSW·interventional·Posted Jun 6, 2022·Updated May 22, 2025

In Brief

A clinical study evaluating SBRT for Radiation Therapy and 2 related conditions. Currently recruiting, targeting 162 participants across 2 sites.

Signals

Enrollment appears stalled

Detailed Summary

To investigate, whether multi-fraction stereotactic body radiation therapy (SBRT) within 3 treatment fractions is non-inferior to the current standard of care of 5 fraction SBRT regarding pain response at 3 months after radiotherapy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRadiation Therapy, Bone Metastases, Pain
CountriesSwitzerland
CollaboratorsKrebsforschung Schweiz, Bern, Switzerland

Timeline

N/ARecruitingOverdue
2023202420252026
First PostedJun 6, 2022
Enrollment StartJun 1, 2022
Primary CompletionMay 31, 2025
Study CompletionMay 31, 2026
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 4.1 years ago

Interventions

SBRTradiation

Stereotactic multiple fraction radiotherapy